This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|March 2, 2015
- Pharmaceutical Technology-03-02-2015
- Volume 39
- Issue 3
Ross Control System Increases Consistency
Author(s)Pharmaceutical Technology Editors
Ross’ SysCon PLC-based Control Systems are designed for sequential control of automated processes including mixing, pumping, chemical dosing, water treatment, fractionation, and heat exchange.
Ross’ SysCon PLC-based Control Systems are designed for sequential control of automated processes including mixing, pumping, chemical dosing, water treatment, fractionation, and heat exchange. The systems can monitor multiple process variables such as temperature, pressure, power loads, weight, and flow at high speeds.
Equipped with touchscreen controls, the systems offer batch-to-batch consistency, error reduction, and increased process safety and efficiency. The system is available in NEMA 12 or NEMA 4X (stainless steel) for washdown applications.
Articles in this issue
over 11 years ago
Vaccine Development and Production Challenges Manufacturersover 11 years ago
Europe Strives for a More Efficient Generic-Drug Approval Frameworkover 11 years ago
Kason Offers Screen Replacementover 11 years ago
GEA Homogenizer Offers Scalabilityover 11 years ago
PolyScience Chiller and Circulator Enhances Temperature Controlover 11 years ago
Industry Expert Q&A with Richard Grantover 11 years ago
Managing Supplier Data Collectionover 11 years ago
The Global Biomanufacturing Outsourcing Marketover 11 years ago
Lyophilization Cycle Optimization of Cell-Derived Productsover 11 years ago
Minimizing Risk during HPAPI ManufactureRelated to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.